It is worth noting that studies have shown that CEP can inhibit the ERK signaling pathway by enhancing the expression of DUSP1, thereby exerting anti-tumor effects on prostate cancer in vitro and in vivo (Dong et al., 2025). This evidence concerns the gene DUSP1 and prostate carcinoma.